Clinical Trial Update: A Study of Ragweed (Ambrosia Artemisiifolia) Allergy Immunotherapy Tablet in Adults With Ragweed Allergies (P05751) [Phase 3]

View source ↗

Summary

Phase 3 results for ALK-Abelló's ragweed pollen allergy immunotherapy tablet in adults with ragweed allergy have been completed and results posted, evaluating e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ragweed Pollen-induced Allergic Rhinitis

Drugs mentioned

• Ragwitek (ragweed pollen extract sublingual tablet)

Snippet

Sponsor: ALK-Abelló A/S | Conditions: Allergy | Phase 3 | Status: COMPLETED | Results posted: 2014-06-05